![Weyl semimetal](/sites/default/files/styles/featured_square_large/public/2024-08/Picture4.jpg?h=b38bf506&itok=nYXXiLDs)
Filter News
Area of Research
News Topics
- (-) Coronavirus (27)
- 3-D Printing/Advanced Manufacturing (82)
- Advanced Reactors (6)
- Artificial Intelligence (20)
- Big Data (15)
- Bioenergy (68)
- Biology (81)
- Biomedical (30)
- Biotechnology (16)
- Buildings (36)
- Chemical Sciences (20)
- Clean Water (21)
- Climate Change (59)
- Composites (19)
- Computer Science (50)
- Critical Materials (9)
- Cybersecurity (9)
- Decarbonization (48)
- Energy Storage (76)
- Environment (141)
- Exascale Computing (6)
- Fossil Energy (3)
- Frontier (6)
- Fusion (2)
- Grid (41)
- High-Performance Computing (25)
- Hydropower (9)
- Isotopes (2)
- Machine Learning (16)
- Materials (49)
- Materials Science (50)
- Mathematics (5)
- Mercury (10)
- Microelectronics (1)
- Microscopy (17)
- Molten Salt (1)
- Nanotechnology (20)
- National Security (9)
- Net Zero (5)
- Neutron Science (100)
- Nuclear Energy (9)
- Partnerships (12)
- Physics (11)
- Polymers (13)
- Quantum Computing (1)
- Quantum Science (8)
- Renewable Energy (2)
- Security (8)
- Simulation (17)
- Space Exploration (6)
- Statistics (1)
- Summit (17)
- Sustainable Energy (93)
- Transformational Challenge Reactor (3)
- Transportation (68)
Media Contacts
![Merlin Theodore holding N95 mask filtration material produced at DOE's Carbon Fiber Technology Facility](/sites/default/files/styles/list_page_thumbnail/public/2021-02/2020-P03000_small.jpg?h=8f9cfe54&itok=ZvzbSegW)
Three technologies developed by ORNL researchers have won National Technology Transfer Awards from the Federal Laboratory Consortium. One of the awards went to a team that adapted melt-blowing capabilities at DOE’s Carbon Fiber Technology Facility to enable the production of filter material for N95 masks in the fight against COVID-19.
![Paul Kent, shown above posing with Summit in April 2018, received the 2020 ORNL Director’s Award for Outstanding Individual Accomplishment in Science and Technology. Credit: ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2020-11/DA_Kent.jpg?h=48cf6540&itok=Ocw9WcgV)
The annual Director's Awards recognized four individuals and teams including awards for leadership in quantum simulation development and application on high-performance computing platforms, and revolutionary advancements in the area of microbial
![An organic solvent and water separate and form nanoclusters on the hydrophobic and hydrophilic sections of plant material, driving the efficient deconstruction of biomass. Credit: Michelle Lehman/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2020-11/dark_image_small.png?h=2e111cc1&itok=drKqW05b)
Experiments led by researchers at ORNL have determined that several hepatitis C drugs can inhibit the SARS-CoV-2 main protease, a crucial protein enzyme that enables the novel coronavirus to reproduce.
![coronavirus](/sites/default/files/styles/list_page_thumbnail/public/2020-11/coronavirus_top10%20%28002%29.png?h=997b30da&itok=7I6TjG_l)
NellOne Therapeutics has licensed a drug delivery system from the Department of Energy’s Oak Ridge National Laboratory that is designed to transport therapeutics directly to cells infected by SARS-CoV-2, the virus causing COVID-19.
![The first neutron structure of the SARS-CoV-2 main protease enzyme revealed unexpected electrical charges in the amino acids cysteine (negative) and histidine (positive), providing key data about the virus’s replication. Credit: Jill Hemman/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2020-10/20-G01620_Protease_PR_proof2_0.jpg?h=3e3883a3&itok=XB_ZEDFQ)
To better understand how the novel coronavirus behaves and how it can be stopped, scientists have completed a three-dimensional map that reveals the location of every atom in an enzyme molecule critical to SARS-CoV-2 reproduction.
A collaboration between the ORNL and a Florida-based medical device manufacturer has led to the addition of 500 jobs in the Miami area to support the mass production of N95 respirator masks.
![Emma Betters Thumbnail](/sites/default/files/styles/list_page_thumbnail/public/2020-10/emma%20betters_sized.jpg?h=e91a75a9&itok=k1X4xVjl)
Growing up in Florida, Emma Betters was fascinated by rockets and for good reason. Any time she wanted to see a space shuttle launch from NASA’s nearby Kennedy Space Center, all she had to do was sit on her front porch.
![Cars and coronavirus](/sites/default/files/styles/list_page_thumbnail/public/2020-08/Transportation-Gauging_pandemic_impact_ORNL_0.jpg?h=4a7d1ed4&itok=Xqx4kknO)
Oak Ridge National Laboratory researchers have developed a machine learning model that could help predict the impact pandemics such as COVID-19 have on fuel demand in the United States.
![Joe Hagerman is expanding connected neighborhood research at ORNL and envisions buildings of the future as resources capable of managing the flow and exchange of energy based on economic and market signals – a concept known as transactive energy. Credit: Carlos Jones/Oak Ridge National Laboratory, U.S. Department of Energy](/sites/default/files/styles/list_page_thumbnail/public/2020-07/2020-P08672%5B2%5D_1.jpg?h=8f9cfe54&itok=CFroD1Y2)
Joe Hagerman, ORNL research lead for buildings integration and controls, understands the impact building technology innovations can have during times of crisis. Over a decade ago, he found himself in the middle of one of the most devastating natural disasters of the century, Hurricane Katrina.
![Analyses of lung fluid cells from COVID-19 patients conducted on the nation’s fastest supercomputer point to gene expression patterns that may explain the runaway symptoms produced by the body’s response to SARS-CoV-2. Credit: Jason B. Smith/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2020-07/cells%20200%5B1%5D.png?h=b95f6d72&itok=V2OxqL5l)
A team led by Dan Jacobson of Oak Ridge National Laboratory used the Summit supercomputer at ORNL to analyze genes from cells in the lung fluid of nine COVID-19 patients compared with 40 control patients.